(Q34756001)

4 August 2017

Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis (English)

1 reference

4 August 2017

C Moore

1

1 reference

4 August 2017

M S Ehlayel

series ordinal

2

1 reference

4 August 2017

J Junprasert

series ordinal

3

1 reference

4 August 2017

R U Sorensen

series ordinal

4

1 reference

4 August 2017

1 November 1998

1 reference

Annals of Allergy, Asthma & Immunology

4 August 2017

1 reference

4 August 2017

81

1 reference

4 August 2017

5

1 reference

4 August 2017

452-458

1 reference

Staphylococcus aureus in the lesions of atopic dermatitis

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Azathioprine in dermatology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Thymopentin therapy reduces the clinical severity of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Effect of n-3 fatty acid supplement to patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Oral evening-primrose-seed oil improves atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Combined UVB and UVA phototherapy of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Tacrolimus ointment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Sodium cromoglycate in childhood atopic dermatitis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Treatment of atopic eczema in children: clinical trial of 10% sodium cromoglycate ointment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

The function and properties of human lung mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Effects of cromolyn on codeine-induced histamine release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Cromolyn does not modulate human allergic skin reactions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Topical cromolyn can modify human allergic skin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Inhibitory effects of various drugs on dual asthmatic responses in wheat flour-sensitive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Disodium cromoglycate inhibits S mu-->S epsilon deletional switch recombination and IgE synthesis in human B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

IgE synthesis by chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Disodium cromoglycate ointment in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Failure of a new topical sodium cromoglycate formulation to improve atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Inhibition of human allergic skin reactions in vivo by pretreatment with cromolyn (disodium cromoglycate)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Chloride conductance activated by external agonists and internal messengers in rat peritoneal mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Asthma prophylaxis agents alter the function of an airway epithelial chloride channel

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Underestimation of treatment effect in crossover trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

Elevated levels of soluble HLA class I (sHLA-I) in children with severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963145-6

7 January 2021

10.1016/S1081-1206(10)63145-6

Identifiers

DOI

1 reference

4 August 2017

1 reference